EVOEvotec SE
$1.57-61% 1Y
$1.57
$1.5352 weeks$4.15
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−41% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 8, 2026
In a downtrend, below its 50- and 200-day averages. Price is −41% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How EVO is trading
Evotec SE is −61% over the past year while the S&P 500 is +18%: 79 points behind the market.
−61%
1-year return · S&P 500 +18%
- vs 200-day average
- −41%
vs 200-day average · a clear downtrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 62%
Below its 52-week high
Details›
- Last close2026-10-08
- $1.57
- 1 monthS&P 500 +1.6%
- −14%
- 1 yearS&P 500 +18%
- −61%
- 5 yearsS&P 500 +86%
- −93%
- vs 50-day average$1.82
- −14%
- 52-week high
- $4.15
- 52-week low
- $1.53
- Annualised volatility
- 62%
| Year | Return |
|---|---|
| 2026 (year to date) | −49% |
| 2025 | −26% |
| 2024 | −65% |
| 2023 | +45% |
| 2022 | −66% |
| 2021 | +29% |
| 2020 | +43% |
| 2019 | +29% |
| 2018 | +24% |
| 2017 | +106% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +3.9% |
| Feb | 10 | 1 of 10 | −7.1% |
| Mar | 10 | 6 of 10 | +1.6% |
| Apr | 10 | 5 of 10 | +0.92% |
| May | 10 | 5 of 10 | +4.7% |
| Jun | 10 | 6 of 10 | +2.8% |
| Jul | 11 | 6 of 11 | −0.15% |
| Aug | 11 | 4 of 11 | +0.76% |
| Sep | 11 | 5 of 11 | −2.6% |
| Oct | 11 | 5 of 11 | −0.99% |
| Nov | 10 | 5 of 10 | +2.5% |
| Dec | 10 | 6 of 10 | +4.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #24 of 41 by RyuScore